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PermeationIn this work, molecular dynamics (MD) simulationswith atomistic details were performed to examine the inﬂu-
ence of the cholesterol on the interactions and the partitioning of the hydrophobic drug ibuprofen in a fully hy-
drated 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) bilayer. Analysis of MD simulations indicated that
ibuprofenmolecules prefer to be located in the hydrophobic acyl chain region of DMPC/cholesterol bilayers. This
distribution decreases the lateral motion of lipid molecules. The presence of ibuprofen molecules in the bilayers
with 0 and 25mol% cholesterol increases the ordering of hydrocarbon tails of lipids whereas for the bilayerswith
50mol% cholesterol, ibuprofenmolecules perturb the ﬂexible chains of DMPC lipids which leads to the reduction
of the acyl chain order parameter. The potential of the mean force (PMF) method was used to calculate the free
energyproﬁle for the transferring of an ibuprofenmolecule from the bulkwater into theDMPC/cholesterolmem-
branes. The PMF studies indicated that the presence of 50 mol% cholesterol in the bilayers increases the free en-
ergy barrier and slows down the permeation of the ibuprofen drug across the DMPC bilayer. This can be due to
the condensing and ordering effects of the cholesterol on the bilayer.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Molecular interactions between the drug molecules and lipid mem-
branes have always been of interest for drug delivery and drug design
investigations. Drug interactions with lipid are important because of
the fact that many drugs are transported in the body by drug delivery
systems based on lipoproteins and liposomes [1,2]. Drugs can exert
their effects via interactions with the lipid bilayer membrane, by
perturbing membrane integrity, increasing the bilayer permeability,
binding to transmembrane protein targets, binding to lipid signaling
molecules, or altering membrane protein conformation [3]. Therefore
in the design of drug and drug delivery systems knowledge about the
interactions of drug with lipids has been the subject of experimental
and computational studies to optimize the drug and drug delivery sys-
tems in the context of their abilities to reach intracellular targets [3].
Among the various computational approaches, molecular dy-
namics (MD) simulation has been frequently employed to study
drug–membrane interactions because it can capture interaction
details on the molecular scale, and also extract thermodynamic proper-
ties that are directly comparable to complementary analytical measure-
ments [4–8]. MD simulations with the potential of mean force (PMF)
calculations were particularly used for study partitioning and transloca-
tion of drugs from the water to the lipid membranes [9–12]. Umbrella
sampling [13] which applies a biasing potential to obtain better samplingis a commonmethod for the PMF calculations [11,12]. AlthoughMD sim-
ulations have been widely used to study drug–lipid membrane systems,
there are only a few works that study the behavior of drug molecules in
the lipid membranes containing cholesterol [14–16].
The study of interaction between drug molecules with lipid
membranes containing cholesterol and their transport mechanism
is very important and useful, with regard to the wide distribution
of cholesterol in biological membranes and its crucial effects on
functional, structural, and dynamical properties of the membranes
[17–21]. Therefore over the past years extensive investigations
were performed to study the inﬂuence of the cholesterol on the
lipid membranes experimentally by using differential scanning
calorimetry (DSC), spectroscopic methods and neutron- and X-ray
scattering methods or computationally by Monte Carlo (MC) and
molecular dynamics (MD) simulation techniques [22–27]. The
results of these investigations indicated that the incorporation of
cholesterol to a lipid bilayer strongly affects its mechanical
and thermodynamic properties [20,28–30] by a) broadening and
eventually eliminating the gel to liquid-crystalline phase transi-
tion; b) inducing new phase regions above the phase transition as
the liquid-disordered, the liquid-ordered and the coexistence of
liquid-ordered and liquid disordered phases; c) increasing the
area per molecule in the gel phase, and reducing the area per mol-
ecule in a liquid-crystalline phase; d) affecting the orientational or-
dering of the hydrocarbon chains and e) decreasing the passive
permeability of the bilayer above and increasing this property
below the main transition temperature.
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antiinﬂammatory (NSAID), analgesic, and antipyretic drugs used
for treatment of rheumatic disorders, pain, and fever and can be
considered as a potent drug against various cancers, Alzheimer's
disease and heart disease [3]. It works by decreasing production
of cyclo-oxygenase (COX)-1 and COX-2 derived prostanoids in
the blood [31]. Based on the results obtained from molecular dy-
namics simulations the ibuprofen has a high partition coefﬁcient
in the DPPC bilayer from the water and the solubility-diffusion
mechanism is the likely mechanism of the permeation of ibuprofen
molecules in the neutral form [9].
The aim of this work is to investigate the behavior of ibuprofen as a
hydrophobic drug inside the fully hydrated DMPC bilayer containing 0,
25 and 50 mol% cholesterol with atomistic detail by using molecular
dynamics (MD) simulations. Several analyses such as the area per
lipid, density distributions, deuterium order parameters, mean square
displacement and tilt angle were performed to elucidate the role of
cholesterol on the structural and dynamic properties of drug molecules
and lipid bilayers and also to explore the localization of the drug and ef-
fects of its presence on bilayers. Moreover, translocation of the Ibu from
the water to the DMPC bilayer with various cholesterol concentrations
was determined by using the potential of the mean constrained force
method. The main energy barrier in translocation of an Ibu molecule
across the membrane was obtained from the free energy proﬁle.Fig. 1.Molecular structures of DMPC lipid, cholesterol and Ibu.
2. Simulation methods
In this workmolecular dynamics (MD) simulations were performed
on fully hydrated dimyristoylphosphatidylcholine (DMPC) lipid bilayers
containing 0, 25 and 50% cholesterol (Chol) mol fractions. All prepara-
tion steps and simulations were carried out using the GROMACS
v5.0.4 software package [32–34]. The pure lipid bilayer consists of 128
DMPC lipids which are arranged in a bilayer, 64 lipidmolecules per leaf-
let, parallel to the x–y plane with three-dimensional periodic boundary
conditions. Then the bilayers with the appropriate cholesterol concen-
trations were created by replacing the suitable number of lipids by cho-
lesterol molecules. The number of lipid molecules and water in the
simulation systems is shown in Table 1. The prepared bilayer was equil-
ibrated byMD simulation with 20 ns time length before insertion of the
drug molecules. Following insertion of 4 drug molecules (Ibu) in one
side of the lipid membrane, the unit cell was ﬁlled with SPC [35]
water. In all simulations, for the DMPC molecules, the partial charges
and force ﬁeld parameters of the Berger et al. [36] were used. The
force ﬁeld parameters and the topology of the cholesterol were based
on the work of Holtje et al. [37]. The topology of the neutral Ibu mole-
cule with the interaction parameters corresponding to the GROMOS
43A1 force ﬁeld was obtained from the PRODRG server [38]. The atomic
charges for the Ibu molecule were taken from Reference [9]. The struc-
tures of DMPC, cholesterol and Ibu molecules are shown in Fig. 1.
Each systemwas initially minimized using the steepest descent algo-
rithm to remove any unfavorable contacts and interactions, followed by
an equilibration simulation of 200 ps with the NVT ensemble. The 100
ns production simulation was run at constant pressure (P = 1 bar) and
temperature (T = 323 K) with a 2 fs time step in the NPT ensembleTable 1
Volume of simulation box V (nm3), number of water, DMPC and cholesterol in the simu-
lation systems: system 1 (0 mol% Chol), system 2 (25 mol% Chol), and system 3
(50 mol% Chol).
System 1 System 2 System 3
V (nm3) 277.95 206.39 170.84
NH2O 4491 2725 2103
NDMPC 128 96 64
NChol 0 32 64and the leapfrog algorithm for integrating the equations of motion. By
using the LINCS algorithm [39] all bond lengths and angles in the systems
were constrained, allowing the 2 fs integration time step. The neighbor
list for computing nonbonded pair forces was updated every 10 steps
with a list cutoff of 1.2 nm. The Particle-Mesh-Ewald summationmethod
[40] with a direct space cutoff of 1.2 nm, a grid spacing of 0.16 nm and an
interpolation order of 4 was used to compute long-range electrostatic in-
teractions. The system pressure was maintained at 1 bar by means of the
Parrinello-Rahman barostat [41] with a coupling time constant of 1.0 ps.
The temperature was maintained at 323 K, using the Nosé–Hoover ther-
mostat scheme [42] with a coupling time constant of 0.5 ps. In this tem-
perature DMPC bilayers with 0, 25, and 50 mol% cholesterol are in the
liquid-disordered, the coexistence of liquid-ordered and liquid-
disordered, and the liquid-ordered phases, respectively [43,44]. Snap-
shots from the production simulations of four Ibu molecules in mem-
branes containing 0, 25 and 50 mol% cholesterol are depicted in Fig. 2.
The free energy proﬁles as the potential of mean force (PMF) for
translocation of one Ibumolecule across the lipid bilayerswere calculat-
ed using umbrella sampling [13] and the weighted histogram analysis
method (WHAM) [45,46]. Starting conﬁgurations were obtained by po-
sitioning the center ofmass (COM) of an Ibumolecule in the bulkwater,
and then pulling it into the bilayer center along the z-axis using the
umbrella method. A harmonic spring with a force constant of
2000 kJ/(mol nm2) and a pulling rate of 0.01 nm/ps was applied on
COM of the drug molecule. These force and rate constants are sufﬁcient
for translocation of drug molecule across the lipid bilayers without
disturbing the bilayer structure. From the obtained trajectory, 14 adja-
cent umbrella windows with a distance change of ~0.2 nmwere select-
ed which spanned the complete space between the bulk water and the
center of bilayer. Each window was simulated for 8 ns where the z dis-
tance between the center of mass (COM) of the drug and DMPC bilayer
(along the membrane normal direction) was constrained, and the drug
Ibuwas allowed to rotate and translate freely in the x–y plane. In several
studies [9,12,47,48] it is shown that this simulation time for eachwindow is
sufﬁcient for equilibration and accurate calculation of the free energy
proﬁles. The PMF proﬁle across the monolayer was calculated by using
Fig. 2. Snapshots of the Ibu molecules in (A) 0 mol%, (B) 25 mol% and (C) 50 mol% cholesterol membranes.
Table 2
The average area per lipid (ADMPC andAChol), the average thickness (h) of the lipid bilayers,
and the volume per DMPC (VDMPC) evaluated for studied simulation systems: System 1
(0 mol% Chol), System 2 (25 mol% Chol), and System 3 (50 mol% Chol).
Systems ADMPC (nm2) AChol (nm2) h (nm) VDMPC (nm3)
1 0.63 (0.01) – 3.40 (0.06) 1.06 (0.01)
2 0.54 (0.01) 0.30 (0.00) 3.94 (0.06) 1.06 (0.01)
3 0.51 (0.01) 0.29(0.00) 4.11 (0.04) 1.04 (0.01)
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be applied to the other monolayer with regard to the symmetric structure
of bilayer.
3. Results and discussion
3.1. Area per lipid
The area per lipid molecule is an essential parameter in charac-
terizing the bilayer structure, which is related to other physical
quantities of membranes, such as the dynamics of lipids and order-
ing of hydrocarbon chains. The procedure used here for calculating
the area per lipid is according to Hofsa et al. [49], using the follow-
ing equations:
ADMPC ¼
2A
NDMPC
1−NCholVChol
V−NwVw
 
ð1Þ
AChol ¼
2A−NDMPCADMPC
NChol
ð2Þ
where ADMPC and AChol are the average area per DMPC and choles-
terol lipids, respectively. A and V are the area and the volume of
simulation box. NDMPC, Nw and NChol stand for the number of par-
ticular molecules in the simulation box (DMPC, water and choles-
terol, respectively). Vw and VChol are the volume occupied by a
water molecule and a cholesterol molecule, respectively. The vol-
ume of a water molecule, Vw, is 0.031546 nm3 [28] and that of
cholesterol molecule, VChol, is 0.593 nm3 [27,28].
The volume per DMPC lipids and the average thickness of the
lipid bilayer (h) were calculated by the following equations:
VDMPC ¼
V−NwVw−NCholVChol
NDMPC
ð3Þ
h ¼ V−NwVw
A
: ð4Þ
The average values for the area per lipids, bilayer thickness and the
volume per DMPC for membranes containing various cholesterol con-
centrations in the presence of Ibu molecules over the last 10 ns of sim-
ulation time were calculated and presented in Table 2. The average
areas per lipid are consistent with the previous experimental and com-
putational data, which justiﬁes the equilibration and the accuracy of the
simulations [50]. As can be seen in this tablewith increasing the content
of cholesterol in themembrane the areas per lipid decreasewhile the bi-
layer thickness increases. This can be related to the rigid structure ofcholesterolwhich causes less perturbation andmore packing and order-
ing in the lipid chains.
3.2. Mass densities
To evaluate the inﬂuence of the cholesterol concentration on the dis-
tribution of drugmolecules in the lipid bilayer, themass density proﬁles
of different molecular components along the axis perpendicular to the
bilayer computed and the resultswere shown in Figs. 3–5. These ﬁgures
indicate that the most probable locations of the Ibu molecules were in
the hydrophobic region of the systems, at the hydrocarbon tails of lipids.
The hydrophobic nature of the Ibu molecules implies that they may be
located outside the polar head groups of the lipid molecules and
water. The previous studies indicated that hydrophilic nature of the
drug molecules, such as psoralen [51], 5-fu [52], ciproﬂoxacin [53] and
hypericin [54], causes an accumulation of the drugs in the vicinity of
the polar head group of lipid bilayers.Whereas themass density proﬁles
of the Ibu molecules in this study indicates that the hydrophobic mole-
cules have lower tendency for accumulation in hydrophilic part of the
bilayers, and diffuse into the hydrophobic part of the bilayer at the hy-
drocarbon tails of lipids. Moreover, these ﬁgures indicate that the cho-
lesterol molecules do not signiﬁcantly alter the distribution position of
the Ibumolecules along themembrane normal. It is seen that increasing
the cholesterol concentration increases the distance between the max-
ima (head to head spacing) of bilayer and thickens it. The extension of
the ﬂat regions between the peaks and the minimums of the density
proﬁles together with the reduction of the density of the middle of the
bilayer indicates the ordering of bilayer with increasing the cholesterol
concentration [50].
3.3. Order parameter
The chain conformational ﬂexibility of lipid can be characterized
by order parameter proﬁles, which in NMR experiments and computa-
tional studies are determined by measuring the deuterium order pa-
rameters Scd. Scd is deﬁned as:
Scd ¼
3
2
cos2θ
 
−1
2
 
ð5Þ
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and the angular brackets indicate the ensemble averaging over
time and over all CD bonds. The computed order parameters of
the DMPC Sn-1 and Sn-2 acyl chains are shown in Fig. 6. From this
ﬁgure it can be concluded that increasing the cholesterol content
in the bilayer increases ordering of the hydrocarbon chains of the
DMPC lipid. This ordering effect of the cholesterol can be due to rel-
atively rigid structure of the cholesterol molecules and also various
types of interactions such as hydrogen bonding with the DMPC
molecules [17,18]. This ﬁgure indicates that incorporation of Ibu
molecules leads to a noticeable ordering effect of both acyl chains
of DMPC lipids in pure bilayer. Previous studies showed that the
presence of various drugs in the phospholipid bilayer can induce
different effects on the order parameters of the lipid tails. For ex-
ample inclusion of articaine [7], pyrene [16] and 5-ﬂuorouracil
[52] into the membrane leads to an increase of the order parame-
ters while benzocaine [55] and prilocaine [56] cause a decrease of
the order parameters. In this study accumulation of the Ibu
molecules in the region of acyl chains forces them to be slightly
more ordered. However the presence of Ibu molecules in the mem-
brane with 50% cholesterol content, which is in the liquid order
state, induces a chain disordering of DMPC lipids. The low free
volume in this region of bilayer may cause the presence of the Ibu
molecules to perturb the ﬂexible chains of DMPC lipids and lead
to a local reduction of the acyl chain order parameter. Such pertur-
bation effects of compound presence in the bilayers containing
cholesterol, were in the liquid order state, have been reported in
both computational [57] and experimental observations [58–60],
which can be related to the lipid molecules' dynamics and confor-
mal perturbation due to the presence of other molecules.Fig. 3. Density proﬁle of the Ibu in the DMPC lipid bilayer.3.4. Mean square displacement (MSD)
Computing the mean square displacement (MSD) is a common way
to evaluate the movements of molecule inside the bilayer. MSD can be
obtained from the MD trajectories by using the following equation:
MSD tð Þ ¼ r t þ t0ð Þ−r t0ð Þ½ 2
D E
ð6Þ
where r is a vector deﬁned by the center of mass of a molecule and the
angle bracket denotes averaging over all possible initial times t0 and
molecules of the given type. The MSD proﬁles of the DMPC and the
drug molecules along the z-axis with different cholesterol concentra-
tions in the bilayer are displayed in Figs. 7 and 8. Fig. 7 reveals that the
lateral motion of the DMPC molecules in the membrane was decreased
with increasing the cholesterol content in themembranes. This is relat-
ed to condensing and ordering effects of cholesterol on the lipid bilayer.
The minimum MSD of the drug molecules is in the membrane with 25
mol% cholesterol which might correspond to the point of percolation
for the Ld phase in the Ld+ Lo coexistence region. However, in themem-
brane with 50 mol% cholesterol, the movement of DMPC molecules is
low, and the presence of high free volume caused the free motion of
Ibu molecules, especially at the hydrocarbon tails of lipids where the
Ibu molecules were located.
3.5. Tilt angle
Computing the average tilt angle of the lipid molecules with respect
to the bilayer normal can provide valuable information about the effectsFig. 4. Density proﬁle of the Ibu in the DMPC bilayer with 25% cholesterol.
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Fig. 6. Deuterium order parameter Scd calculated for the Sn-1 (A) and Sn-2 (B) of DMPC
acyl chains in the simulated systems.
Fig. 5. Density proﬁle of the Ibu in the DMPC bilayer with 50% cholesterol.
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the bilayer normal and the vectors connecting atoms P8–N4, C29–C17
and C46–C34 were deﬁned as the tilt angles of the headgroup and
Sn-1 and Sn-2 acyl chains of the DMPC, respectively. The ring part
and side-chain tilt angles of cholesterol were deﬁned as the angles
between the vectors connecting C21–C5 and C27–C21 of the choles-
terol molecule and the bilayer normal. An angle of 0° corresponds to
the vector aligned parallel to the bilayer normal, while an angle of
90° corresponds to the vector perpendicular to the bilayer normal.
The average tilt angles for various parts of lipids in the membrane
with different cholesterol concentrations in the presence and ab-
sence of the drug molecules are presented in Table 3. As seen in
this table with increasing the cholesterol concentration in the mem-
brane, the DMPC tails tilt angles and cholesterol tilt angles decrease
which imply that the lipids have more orientation order and as a re-
sult the bilayer is more packed. Moreover, the results of this table in-
dicate that the presence of Ibu molecules in the bilayer without
cholesterol content decreases the average tilt angles which can be
related to the compression of lipids and reduction of the in-plane
spanning. For the membrane with 50 mol%, insertion of Ibu mole-
cules causes an increase in the tilt angles of DMPC tails. This is in
agreement with the obtained results by order parameter analysis as
mentioned in Section 3.3. The orientation of Ibu molecules in a bilay-
er was measured by calculating the angles between the vectors
connecting CAH and CAE of the Ibu molecule and the bilayer normal.
The average values of this angle are 68.75, 54.90 and 49.96 for Ibu
molecules in the membranes with 0, 25, and 50 mol% cholesterol, re-
spectively. It is indicated that with increasing the cholesterolconcentration in the membrane, the average tilt angles of Ibu de-
crease which implies that the drug was aligned parallel to the bilayer
normal. This can be explained by increasing the ordering of the lipids
and decreasing the space and compression of lipids due to the pres-
ence of cholesterol molecules which cause lipid chains forcing drugs
to be slightly more ordered.
3.6. Free energy analysis
The free energy proﬁles calculated by the potential of mean force for
transferring an Ibu molecule from the bulk water to the center of the
DMPC bilayer containing various cholesterol concentrations are shown
in Fig. 9. As seen in this ﬁgure the free energy decreases from the
water to the inside of the bilayer which is attributed to the transfer of
Ibu molecule as a hydrophobic drug from the water to the hydrophobic
region of bilayer. A similar decrease of the free energy for transferring
the Ibu molecule from the water to the middle of phospholipid bilayer
was reported in other PMF studies [9,10]. As indicated in these studies
[9,10] low polarity of ibuprofen molecules causes a low Coulomb inter-
action between drug and water or drug and polar groups of lipids, and
also the number of hydrogen bonding between Ibu andwater and lipids
is negligible, especially in deeper part of bilayer. For these reasons, there
aren't large energy barriers to overcome when passing Ibu molecule
from the water to the middle of phospholipid bilayer. Previous studies
[47,51,52] showed that by transferring hydrophilic drugs from the
Fig. 8. The mean square displacement of the Ibu in the simulated systems.
Fig. 7. The mean square displacement of the DMPC lipids in the simulated systems.
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compared to the Ibu molecule. This increase is proportional to the size
and hydrophobicity of the solute [47]. A comparison of free energy pro-
ﬁles shown in Fig. 9 indicates that the magnitude of the free energy
change for transferring of Ibu molecule from the water to the
bilayer with 50 mol% cholesterol, is about 25 kJ/mol, which is lower
than that of the bilayers with 0 and 25 mol% cholesterol, which is
about 55 kJ/mol. The direct relation between drug partitioning into
themembrane and the free energy change for transferring of drug mol-
ecule from the water to themembrane [9,47] suggests that partitioning
of Ibu molecule in the bilayers with 0 and 25mol% cholesterol is higherTable 3
The average tilt angles evaluated for lipid segments in studied simulation systems in the presen
System 3 (50 mol% Chol).
Systems P–N angle Sn-1 angle
1 without drug 80.90 (12.92) 33.88 (6.15)
2 without drug 80.65 (18.69) 21.54 (4.46)
3 without drug 81.15 (14.86) 11.82 (1.68)
1 with drug 80.08 (8.09) 32.48 (2.54)
2 with drug 80.45 (10.65) 21.41 (3.34)
3 with drug 81.45 (7.59) 13.16 (1.03)than partitioning in the bilayer with 50 mol% cholesterol. In the DMPC
membrane with 50 mol% cholesterol the lipid tails are highly ordered
and the favorable van der Waals interactions are formed between the
nearby cholesterol and other lipid tails [47]. Therefore, upon the inser-
tion of Ibu molecule, strong van der Waals contacts are broken and
large voids are formed above and below the drug molecule. Whereas
in the DMPC membrane with 0 and 25 mol% cholesterol, low ordering
of the lipid tails and the weak interactions facilitate the Ibu molecule
transfer into the membrane. The PMF proﬁles indicate that an Ibu
molecule for penetration into the membrane should pass a free energy
barrier located in themiddle of the bilayer. The height of this barrier can
be measured as the difference between the absolute free energy
minimum and the maximum of free energy in the middle region of bi-
layer which are 8.9, 3.7 and 14.3 kJ/mol for membranes with 0, 25,
and 50 mol% cholesterol. In a previous experimental study [61], it is
shown that incorporation of cholesterol to the DMPC bilayer increases
the hydrophobicity of the membrane interior, and increases the hydro-
phobic barrier to the permeation of the polar molecules. With regard to
nonpolarity of Ibu molecules and its hydrophobic nature, incorporation
of 25 mol% cholesterol to the DMPC bilayer doesn't alter its barrier to
the Ibu permeation, while for membrane with 50 mol% cholesterol the
barrier was increased signiﬁcantly. This increasing for membrane with
50 mol% cholesterol can be related to the existence of membrane in
the liquid order state and high ordering and compactness of lipids in
the membrane. Therefore the values of free energy barriers indicate
that the existence of phospholipid bilayer in the liquid order state
slows down the Ibu or other hydrophobic molecules transport across
the membranes and decrease their permeability.4. Conclusion
In thiswork,molecular dynamics (MD) simulationswere carried out
to investigate the behavior of ibuprofen as a hydrophobic nonsteroidal
antiinﬂammatory drug in fully hydrated 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC) bilayer with varying amounts of cholesterol
(0, 25 and 50 mol%). Several analyses were performed to study the pre-
cise location of the ibuprofen molecules inside the membrane and how
it alters the structural and dynamic properties of the membrane and
also the effects of the cholesterol. The results indicated that ibuprofen
molecules were preferentially accumulated in the hydrophobic acyl
chain region of the lipid bilayers which causes packing and ordering of
lipids decreasing their lateral motion. However, for bilayer with 50
mol% cholesterol, the presence of ibuprofen molecules in the bilayer in-
duces some disordering in the DMPC lipid tails. The free energy proﬁles
for the permeation of the ibuprofen molecule across the DMPC/Chol
membranes were determined by the potential of the mean force
(PMF)method. The free energy for transferring of Ibu molecule as a hy-
drophobic drug from thewater to themiddle of bilayer decreases. From
the free energy proﬁle, it was concluded that the existence of the 50
mol% cholesterol in the bilayer increases the free energy barrier and
slows down the translocation of the ibuprofen molecule across the
DMPC bilayer.ce and absence of drugmolecules: System 1 (0 mol% Chol), System 2 (25 mol% Chol), and
Sn-2 angle Chol ring part angle Chol side chain angle
36.45 (6.63) – –
22.23 (5.01) 21.82 (2.75) 28.50 (3.69)
12.84 (1.89) 11.64 (1.30) 19.54 (1.71)
33.92 (2.87) – –
22.75 (2.71) 19.95 (1.75) 29.56 (2.36)
13.02 (1.09) 11.76 (1.26) 20.35 (1.71)
Fig. 9. Free energy proﬁles of Ibu across theDMPC/Cholmembrane at different cholesterol
concentrations.
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